PHILADELPHIA, March 6, 2025 /PRNewswire/ -- Integral Molecular, a leader in antibody discovery against membrane proteins, is pleased to announce that its out-licensed anti-Claudin 6 (CLDN6 ...

TEDC1 and TEDC2, functions in generating centriolar triplet microtubules, and that this is crucial for the proper formation of centriolar subdomains and the stability of centrioles throughout the cell ...

Strategies to optimize structures A detailed knowledge of antibody structure and activity now allows researchers to engineer primary antibodies on a more rational basis. This can yield more ...

Artificial Intelligence (AI) and deep learning have already transformed several aspects of small molecule ... a structure-based approach, where their model is trained on millions of Antibody ...

The “NeuN Antibody Market” research report provides a detailed analysis of key segments driving market growth, covering market size, share, dynamics, opportunities, and challenges. It highlights ...

The global Antibody-drug Conjugates Market size was valued at USD 2763.08 million in 2024 and is expected to grow at a CAGR of 3.14% from 2025 to 2033 Browse Detailed TOC of Antibody-drug ...

DeepBioLab is an AI-focused platform designed to explore, build, and share advanced AI algorithms. It features educational content, projects, and research on topics like deep learning, reinforcement ...

Recent advances in synaptic proteome approaches, such as fluorescence-activated synaptosome sorting (FASS) and proximity labeling, have allowed for a detailed and spatial analysis of many ... The ...

Mar. 10, 2025 — Researchers shed new light on G-quadruplexes, a type of secondary DNA structure that has attracted attention as a potential therapeutic target in ...

Recombinant human TSH (rhTSH) was developed to provide TSH stimulation without the requirement for THST withdrawal and the resultant metabolic disturbance, and without the drawbacks associated with ...

Share on Pinterest Scientists have found that an antibody treatment prevented a decline in muscle mass and bone density after using GLP-1 drugs. Rob and Julia Campbell/Stocksy Aging and limited ...